Diabetes research news (and anything involving lab mice) can sometimes make our eyes gloss over, as it seems we’re hearing about some new scientific “breakthrough” every other day.
But we took a little more interest recently when hearing about a new line of D-research that seems to have a Star Trek spin to it!
Yup, apparently this research is exploring how our insulin-producing cells basically put on a Romulan cloaking device to hide from diabetes!…
Read more »
By
WilD on
September 8, 2012
Happy Saturday! Welcome back to Ask D’Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. This week, Wil offers thoughts on sugar absorption in people with diabetes (not quite what you might think of) and how not every mix of insulin is a good idea
{Got your own questions? Email us at AskDMine@diabetesmine.com}
Valeri, type 2 from Texas, writes: I was diagnosed with type 2 diabetes two years…
Read more »
By
AmyT on
January 17, 2012
In the area of beta cell preservation, there’s a (sort of) new name in the spotlight: Andromeda Biotech, Ltd. with its DiaPep277 treatment. Based in Israel, this company announced last month that phase III clinical trials showed significant preservation of C-peptide levels, a marker for assessing insulin secretion by pancreatic cells. Andromeda joins the ranks of companies like Tolerx and Macrogenics/Lilly, who’ve been vocal about their work to preserve beta cell functioning in newly diagnosed patients…
Read more »
By
AmyT on
January 10, 2009
Finally, a press release that is unquestionably post-worthy: on Friday, the legendary Joslin Diabetes Center in Boston announced that it’s received a million-dollar grant to support type 1 diabetes research.
The money comes from a wealthy patient with his own philanthropic organization: the Thomas J. Beatson, Jr. Foundation. Beatson lives in Phoenix, AZ, and is also a Joslin Medalist for living with type 1 diabetes for 50 or more years. He’s given funds to the…
Read more »
